RXO, Inc. Form 8-K Summary
Business Context and Reporting Period
RXO, Inc. (RXO), a Delaware corporation, filed this Current Report on Form 8-K on September 11, 2024, regarding events occurring on September 9 and September 10, 2024. The filing details the entry into a material definitive agreement for a public offering of common stock.
Key Financial Metrics and Transaction Details
- Shares Sold: 19,230,770 shares of common stock.
- Offering Price: $26.00 per share.
- Optional Shares: Underwriters granted an option to purchase up to 2,884,615 additional shares.
- Net Proceeds: Approximately $479 million (after deducting estimated offering expenses).
- Underwriters: Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., and Morgan Stanley & Co. LLC.
This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity metrics for the company's ongoing operations.
Material Changes
The primary material change is the execution of the underwriting agreement and the subsequent pricing of the offering, which will significantly increase the company's cash position upon closing. No comparative financial period data is included in this specific filing.
Outlook, Risks, and Contingencies
The filing references customary representations, warranties, and covenants within the Underwriting Agreement. The Company agreed to indemnify the Underwriters against certain liabilities, including those under the Securities Act of 1933. The sale was made pursuant to a registration statement on Form S-3ASR. No specific forward-looking guidance or new risk factors were detailed in the text of this 8-K beyond standard underwriting terms.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received after all expenses.
- Confirm whether the underwriters exercised the option to purchase the 2,884,615 Optional Shares.
- Review the final prospectus supplement (filed September 10, 2024) for updated use of proceeds and risk factors.
- Assess the impact of the new share issuance on existing shareholder dilution.